Transparency Market Research

Antibody Specificity Testing Market

Antibody Specificity Testing Market is expected to Reach to US $1.9 Bn by 2035, Driven by Rising Demand for Personalized ...
Technology Networks

Modernizing Microarrays for Faster, Scalable Genetic Discovery

To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo ...
GEN

Efficiency, Sustainability Drive Thermo Fisher’s New Microarray Data Analysis Solution

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...
Morningstar

Thermo Fisher Scientific Fuels the Future of Multi-omics Research with the Launch of Next-Generation Microarray Solution

New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research Thermo Fisher Scientific, the ...
MarketWatch

Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology

The MarketWatch News Department was not involved in the creation of this content. -- Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch" technology and utilizes ...
WJTV

Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology

Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technology Research builds on Emory’s ...
Business Wire

Newly Published Data Supports Effective Delivery of DNA-Based Vaccines Using Vaxxas’ High-Density Microarray Patch (HD-MAP) Delivery Technology

Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...